Symptoms of Major Depressive Disorder Scale: Performance of a Novel Patient-Reported Symptom Measure-Reference-Cited by-同舟云学术

Symptoms of Major Depressive Disorder Scale: Performance of a Novel Patient-Reported Symptom Measure

Published:2019-08 Issue:8 Volume:22 Page:906-915
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Bushnell Donald M.,McCarrier Kelly P.,Bush Elizabeth Nicole,Abraham Lucy,Jamieson Carol,McDougall Fiona,Trivedi Madhukar H.,Thase Michael E.,Carpenter Linda,Coons Stephen Joel

Funder

Critical Path Public-Private Partnerships

FDA

AbbVie

Bristol-Myers Squibb

Eli Lilly and Company

Forest Research Institute

Janssen

Pfizer

Roche Products Ltd

Shire

Sunovion

Takeda

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference36 articles.

1. Major depressive disorder: understanding the significance of residual symptoms and balancing efficacy with tolerability;Culpepper;Am J Med,2015

2. Patient-reported outcomes to support medical product labeling claims: FDA perspective;Patrick;Value Health,2007

3. Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification: PRO Task Force Report;Rothman;Value Health,2009

4. Content validity—establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 1–Eliciting Concepts for a New PRO Instrument;Patrick;Value Health,2011

5. Content validity—establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2–Assessing Respondent Understanding;Patrick;Value Health,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of esketamine nasal spray on depressive symptom severity in adults with treatment-resistant depression and associations between the Montgomery–Åsberg Depression Rating Scale and the 9-item Patient Health Questionnaire;CNS Spectrums;2024-04-01

2. Antidepressant medications have evolved in terms of speed of onset of efficacy: How can we best measure antidepressant treatment response?;Current Medical Research and Opinion;2024-03-15

3. Goal setting and goal attainment in patients with major depressive disorder: a narrative review on shared decision making in clinical practice;Current Medical Research and Opinion;2024-02-19

4. Recommendations for selection and adaptation of rating scales for clinical studies of rapid-acting antidepressants;Frontiers in Psychiatry;2023-06-02

5. Qualitative Analysis of the Content Validity of the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) in Schizophrenia: A Multi-Stakeholder Perspective;Schizophrenia Bulletin Open;2023-01-01